Ogsiveo Tablet, Film Coated
Product Images NDC 82448-150

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Ogsiveo (NDC 82448-150). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Springworks Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Structural Formula For Nirogacestat Hydrobromide Is: Ogsiveo Oral Tablets Contain Nirogacestat (as Nirogacestat Hydrobromide), A Gamma (ɣ) Secretase Inhibitor. Nirogacestat Hydrobromide Is Chemically Known As (s)-2-(((s)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-n-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1h-imidazol-4-yl) Pentanamide Dihydrobromide. The Empirical Formula Is C27h43br2f2n5o And The Molecular Weight Is 651.48 G/mol. Nirogacestat Hydrobromide Is A White To Off White Powder With An Aqueous Solubility Of 11.4 mg/ml And A Ph Of 4.4 In Water At 25c. Nirogacestat Dihydrobromide Is Highly Soluble At Low Ph, However The Solubility Significantly Decreases At Ph > 6.0. The Molecule Has Pka’s Of 5.77 And 7.13. (Nirogacestat 01)

FDA Label Image

Figure 1 (Nirogacestat 02)

FDA Label Image

Principal Display Panelndc 82448-050-18rx Onlyogsiveo50 mg180 Tablets (Nirogacestat 03)

FDA Label Image

Principal Display Panelndc 82448-050-18rx Onlyogsiveo50 mg180 Tablets (Nirogacestat 04)

FDA Label Image

Principal Display Panelndc 82448-050-18rx Onlyogsiveo50 mg180 Tablets (Nirogacestat 05)

FDA Label Image

Principal Display Panelndc 82448-050-18rx Onlyogsiveo50 mg180 Tablets (Nirogacestat 06)